ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
www.zerohedge.com
Early on in the pandemic, before the vaccines were available, the Southern Brazilian city of Itajai offered Ivermectin as a prophylaxis against the disease.
Between July and December of 2020, roughly 220,000 people were offered a dose of 0.2mg/kg/day (roughly 18mg for a 200lb person) as an optional treatment for 2 days, once every two weeks.
133,051 people took them up on it, while 87,466 did not.
After analyzing the data, a team of researchers spanning several Brazilian institutes, the University of Toronto, and Columbia's EAFIT concluded in a December
pre-print study that
hospitalization and mortality rates were cut in half over the seven month period among the Ivermectin group
The authors adjusted for relevant confounding variables, including age, sex, medical history, previous diseases, and other conditions.
The analysis contradicts an October report by
Business Insider which claims, based on a Brazilian ICU doctor's
anecdotal evidence, that the experiment was a failure.